The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 13, 2018
Filed:
Sep. 05, 2014
Applicants:
Shanghai Hengrui Pharmaceutical Co., Ltd., Shanghai, CN;
Jiangsu Hengrui Medicine Co., Ltd., Lianyungang, Jiangsu, CN;
Inventors:
Wangyang Tu, Shanghai, CN;
Haitang Zhang, Shanghai, CN;
Guoji Xu, Shanghai, CN;
Jiangtao Chi, Shanghai, CN;
Assignees:
Shanghai Hengrui Pharmaceutical Co., Ltd., Shanghai, CN;
Jiangsu Hengrui Medicine Co., Ltd., Lianyungang, Jiangsu, CN;
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/443 (2006.01); C07D 213/82 (2006.01); C07D 405/12 (2006.01); C07D 471/04 (2006.01); A61K 31/4412 (2006.01); A61K 31/444 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
C07D 213/82 (2013.01); A61K 31/443 (2013.01); A61K 31/444 (2013.01); A61K 31/4412 (2013.01); A61K 45/06 (2013.01); C07D 405/12 (2013.01); C07D 471/04 (2013.01);
Abstract
Pyridone derivatives, methods of preparing the pyridone derivatives, and methods of using the pyridone derivatives are provided. In particular, pyridone derivatives of formula (I), and pharmaceutical salts thereof are provided. The pyridone derivatives are useful as mitogen-activated protein kinase kinase (MEK) inhibitors, and can be used as therapeutic agents for treating cancer.